Helius Medical Technologies (HSDT) said Wednesday it received a Nasdaq hearings panel notice on Monday that the company has fulfilled compliance with the regulator's equity requirement for continued listing.
The company will be subject to a mandatory panel monitor for one year, effective immediately, Helius said.
Shares of the company were down 2.2% in recent Wednesday trading.
Price: 8.71, Change: -0.20, Percent Change: -2.24